(Q43559127)

24 November 2017

Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia (English)

1 reference

24 November 2017

0 references

0 references

M P Salyers

1

1 reference

PubMed ID

11278158

24 November 2017

K T Mueser

series ordinal

2

1 reference

PubMed ID

11278158

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

Schizophrenia Research

1 reference

24 November 2017

48

1 reference

24 November 2017

1

1 reference

24 November 2017

109-123

1 reference

Problem drinking in hospitalized schizophrenic patients.

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Substance abuse in schizophrenia: service utilization and costs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Hallucinogenic drugs as precipitants of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Relationships between symptoms of schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Risk factors for homelessness among women with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Risk factors for homelessness among schizophrenic men: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Drug abuse in a young psychiatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Substance abuse and family relationships of persons with severe mental illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Increased tardive dyskinesia in alcohol-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Suicide attempts associated with akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Family Attitudes and Patient Social Adjustment in a Longitudinal Study of Outpatient Schizophrenics Receiving Low-Dose Neuroleptics: The Family’s View

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Dual diagnosis: a review of etiological theories

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Clinical effects of recent cocaine use on patients with acute schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Intraclass correlations: uses in assessing rater reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

The many faces of Akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900063-3

7 January 2021

10.1016/S0920-9964(00)00063-3

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11278158